| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.98B | +7.8% |
| Cost of Revenue | $621.7M | +8.6% |
| Gross Profit | $2.36B | +7.6% |
| R&D Expense | $588.5M | +9.1% |
| SG&A Expense | $376.0M | -10.4% |
| Operating Income | $199.9M | +532.0% |
| Pre-tax Income | $247.9M | +164.7% |
| Income Tax | -$819.9M | -4262.4% |
| Net Income | $1.07B |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $648.6M | -18.6% |
| Accounts Receivable | $429.6M | -2.2% |
| Current Assets | $1.49B | -5.0% |
| Total Assets | $4.01B | +35.0% |
| Current Liabilities | $1.83B | +10.3% |
| Total Liabilities | $2.01B | +9.1% |
| Stockholders' Equity | $2.00B | +77.3% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.02B | +3.9% |
| Capital Expenditures | $97.0M | +5.0% |
| Investing Cash Flow | -$312.9M | -801.3% |
| Financing Cash Flow | -$838.8M | +11.3% |
| Free Cash Flow | $920.3M | +3.7% |
| +1343.5% |
| EPS (Basic) | $5.23 | +1352.8% |
| EPS (Diluted) | $5.08 | +1311.1% |